Personalized neoantigen mRNA-based vaccine(Shenzhen Xinhe Biomedical Technology Co Ltd)

N/A

Report date: 2022/07/18 09:19:03

Base Information

Drug NamePersonalized neoantigen mRNA-based vaccine(Shenzhen Xinhe Biomedical Technology Co Ltd)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Neocura Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Neocura Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A